Solid Biosciences (SLDB) Shares Outstanding (Diluted Average) (2020 - 2026)
Quarterly results put Shares Outstanding (Diluted Average) at $109.8 million for Q1 2026, up 65.53% from a year ago — trailing twelve months through Mar 2026 was $109.8 million (up 65.53% YoY), and the annual figure for FY2025 was $87.5 million, up 114.38%.
Solid Biosciences has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $109.8 million for Q1 2026.
- Shares Outstanding (Diluted Average) reached $109.8 million in Q1 2026 per SLDB's latest filing, up from $87.5 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $109.8 million in Q1 2026 and bottomed at $7.5 million in Q1 2022.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $38.2 million (2024), compared with a mean of $41.9 million.
- The largest annual shift saw Shares Outstanding (Diluted Average) crashed 92.55% in 2022 before it surged 166.3% in 2023.
- Over 5 years, Shares Outstanding (Diluted Average) stood at $8.5 million in 2022, then skyrocketed by 133.6% to $19.9 million in 2023, then skyrocketed by 105.27% to $40.8 million in 2024, then skyrocketed by 114.38% to $87.5 million in 2025, then grew by 25.49% to $109.8 million in 2026.
- Business Quant data shows Shares Outstanding (Diluted Average) for SLDB at $109.8 million in Q1 2026, $87.5 million in Q4 2025, and $85.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 109.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.81 Mn |
| Dec 31, 2025 | 87.50 Mn |
| Sep 30, 2025 | 85.07 Mn |
| Jun 30, 2025 | 94.14 Mn |
| Mar 31, 2025 | 66.34 Mn |
| Dec 31, 2024 | 40.82 Mn |
| Sep 30, 2024 | 41.44 Mn |
| Jun 30, 2024 | 39.54 Mn |
| Mar 31, 2024 | 38.16 Mn |
| Dec 31, 2023 | 19.88 Mn |
| Sep 30, 2023 | 20.06 Mn |
| Jun 30, 2023 | 19.66 Mn |
| Mar 31, 2023 | 19.57 Mn |
| Dec 31, 2022 | 8.51 Mn |
| Sep 30, 2022 | 7.53 Mn |
| Jun 30, 2022 | 7.52 Mn |
| Mar 31, 2022 | 7.51 Mn |
| Dec 31, 2021 | 7.12 Mn |
| Sep 30, 2021 | 7.49 Mn |
| Jun 30, 2021 | 100.85 Mn |
| Dec 31, 2020 | 3.46 Mn |